Dr. Michael McGrath, M.D.
Medical Director at Banyan Palm Springs
At Banyan Treatment Centers, we believe that the heart of effective treatment lies in the expertise, compassion, and dedication of our clinical leaders. Our medical directors play a vital role in shaping the care we provide, ensuring that every client receives evidence-based, individualized treatment tailored to their needs.
In this Q&A series, we sit down with our medical directors to give you an inside look at their perspectives, experience, and approach to behavioral health. From discussing the latest advancements in treatment to sharing what inspires them in their work, these conversations highlight the passion and knowledge that guide our programs.
In this article, you’ll find insights from Dr. Michael McGrath, the Medical Director of Banyan Palm Springs, our detox, residential addiction treatment facility, and day treatment program located in Palm Springs, California. With his extensive experience in the field of addiction medicine, Dr. McGrath shares his perspective on effective treatment approaches, the challenges clients face in early recovery, and the importance of compassionate, evidence-based care.
If concerns about addiction are affecting your daily life, the team at our drug and alcohol rehab in Boca Raton, FL can guide you through intensive outpatient programs options designed for lasting recovery.
Q: How do you and your team approach individualized treatment planning?
A: We take into consideration a client's medical and treatment history, personal preferences and cultural experiences when approaching and designing a treatment plan.
Q: How do you ensure evidence-based practices are integrated into daily care?
A: By making sure diagnoses are as accurate as possible. This is done by pursuing subjective and objective data to arrive at the working diagnoses. With an accurate diagnosis the research and guidelines can be reviewed by providers to design a treatment plan.
Q:How do you combine multiple evidence-based modalities to create individualized treatment plans?
A: Having a menu of treatments from comfort/withdrawal and MAT choices to combine with the latest types of psychosocial therapies and mutual help organization options a client can be assured of an evidence based multi-modal treatment.
Q: How do you measure the effectiveness of evidence-based therapies over time?
A: Watching the literature for follow up and meta-analysis studies is the best way. Second best would be compiling data from providers that are part of the same organization, and lastly using one could use anecdotal experience with an evidence-based treatment.
The connection between addiction and long-term health underscores the importance of professional support, like the residential addiction treatment offered at our inpatient rehab facility in Cathedral City, CA.
Questions about our Facilities or Programs?
Our admissions coordinators are available 24/7 to answer any questions you may have as you consider whether treatment at Banyan is right for you or your loved one.
Q: How do you determine when medication-assisted treatment (MAT) is appropriate for a patient?
A: All patients with alcohol, nicotine or opioid use disorders are candidates for MAT and should be educated and offered MAT options.
Q: Can you explain the role of FDA-approved medications (e.g., Suboxone, Vivitrol, Methadone) in addiction recovery?
A: Partial agonists such as buprenorphine activate receptors providing some positive reinforcing rewarding effects in a manner that is less likely to cause overdose than full agonists such as Methadone. Methadone as a full agonist has more positive reinforcing effects and may fit better with patients wanting or needing that level of effect. Antagonists such as Vivitrol offer little to no positive reinforcement but result in some stabilization of the involved receptors over time leading to decreased craving and severity of binging.
Q: What are some of your medical findings that have been helpful to those battling a substance use problem?
A: Helping persons with a SUD understand the disease model of addiction as a chronic illness with genetic, epigenetic (nurturing versus adverse childhood events and trauma) and environmental elements helps patients understand the complexity of their SUD. With that understanding the goal of SUD treatment as addressing these various contributions becomes more clear. Also using leverages and extrinsic motivation from legal issues or interventions from families or employers can be a powerful motivator for success.
Q: What advice do you have for someone considering entering treatment for the first time?
A: Be humble and curious and know that you are among people that respect you as a good person suffering from a dangerous disease.
Getting into treatment is easy with our free insurance verification
"*" indicates required fields
Q: If there’s one message you’d like people struggling with addiction or mental health to know, what would it be?
A: You are worthy and deserving of treatment to experience relief of your suffering and discovering a life worth living.
Q: How has behavioral health treatment changed in recent years?
A: In recent years behavioral health treatment has become increasingly delivered by mid-level practitioners such as nurse practitioners and physician assistants. They work from a limited foundation of training and experience and rely on symptom checklists and templates to arrive at diagnoses and treatments. This is often adequate for competent care but limits the comprehensiveness of the engagement. The other change is the increasing sensitivity and decreasing specificity of trendy diagnosing of conditions such as ADD and ASD. These diagnoses are connected with desired treatments and so are mutually reinforcing for both patients and diagnosticians.
Q: What innovative therapies or approaches are you most excited about right now?
A: Exploring other neurotransmitter systems other than the monoamines for mood, thought and anxiety disorders. The NMDA, acetylcholine and cannabinoid receptors will likely be exploited more scientifically. The serotonergic alteration by hallucinogens will likely also lead to some breakthroughs in treatment.
Q: What trends do you see shaping the future of behavioral health and addiction treatment?
A: BH and Addiction treatment will lean towards more interventional treatments such as TMS and the innovative use of new medications. This will be driven by the marketing of these products to consumers and providers. National Telehealth Corporations will begin to dominate treatment by hiring mid-level practitioners and psychiatrists that want to avoid the hassle of dealing with managed care and are willing to give up a substantial percentage of their billing that will be paid to the corporation. The emphasis on the psychology of and the psychosocial treatment of, BH and addiction disorders will diminish as provider reimbursement for said continues to dwindle.
Q: What research areas excite you most in terms of advancing treatment outcomes?
A: More sophisticated medications targeting novel approaches to NMDA, cannabinoid receptors and other psychotropic neurotransmitter systems. Also any research that demonstrates how a lifestyle medicine approach benefits outcomes in chronic BH and addictive disorders would be welcome.
To learn more about treatment options for substance use disorder, contact the professionals at our residential treatment center in Castle Rock, CO and take the first step toward a healthier life.
